Scholtz & Company’s Inogen INGN Stock Holding History

Scholtz & Company’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,410	Closed	-$834K	–	46
2016 Q4	$834K	Buy	+12,410	New	+$765K	0.72%	36

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Scholtz & Company's INGN Position: Q1 2017 in Review

Scholtz & Company sold out of Inogen (INGN) in Q1 2017, closing a stake of 12,410 shares — an estimated $834K sold.

Scholtz & Company first reported a position in INGN in Q4 2016 and held it in 1 quarter. The position peaked at $834K in Q4 2016. 194 funds tracked by Wall St. Rank hold INGN as of Q1 2017.

Scholtz & Company reported no remaining Inogen position as of Q1 2017 after selling out during the quarter.
Scholtz & Company sold 12,410 Inogen shares in Q1 2017, an estimated $834K.
Scholtz & Company first reported a position in Inogen in Q4 2016 and held it in 1 quarter.
Scholtz & Company's Inogen position peaked at $834K in Q4 2016.
194 funds tracked by Wall St. Rank held Inogen as of Q1 2017.

Based on Scholtz & Company's 13F filing for Q1 2017, filed 12 May 2017.